ImmunityBio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.27
|
0.00
|
0.27
|
100.00%
|
|
2022-12-31
|
-0.22
|
0.00
|
0.22
|
100.00%
|
|
2022-09-30
|
-0.23
|
-0.28
|
-0.05
|
-21.74%
|
|
2022-06-30
|
-0.24
|
-0.24
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.22
|
-0.26
|
-0.04
|
-18.18%
|
|
2021-12-31
|
-0.21
|
-0.23
|
-0.02
|
-9.52%
|
|
2021-09-30
|
-0.20
|
-0.22
|
-0.02
|
-10.00%
|
|
2021-06-30
|
-0.12
|
-0.23
|
-0.11
|
-91.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.78
|
|
2021-12-31
|
-0.89
|
|
2020-12-31
|
-0.89
|
|
2019-12-31
|
-0.71
|
|
2018-12-31
|
-1.22
|
|
2017-12-31
|
-1.20
|
|
2016-12-31
|
-1.47
|
|
2015-12-31
|
-2.81
|